This ESC joint scientific statement provides a comprehensive overview of the vascular, genetic, and hormonal pathophysiological mechanisms underlying Takotsubo syndrome.
Does not yet change Takotsubo management; extends synthesis of vascular, hormonal, genetic, and chronic factors for future research.
While the first part of the scientific statement on the pathophysiology of Takotsubo syndrome was focused on catecholamines and the sympathetic nervous system, in the second part we focus on the vascular pathophysiology including coronary and systemic vascular responses, the role of the central and peripheral nervous systems during the acute phase and abnormalities in the subacute phase, the gender differences and integrated effects of sex hormones, genetics of Takotsubo syndrome including insights from microRNA studies and inducible pluripotent stem cell models of Takotsubo syndrome. We then discuss the chronic abnormalities of cardiovascular physiology in survivors, the limitations of current clinical and preclinical studies, the implications of the knowledge of pathophysiology for clinical management and future perspectives and directions of research.
No takes yet. Share an insight, caveat, or question.
Ömerovic et al. (2021) conducted a review in Takotsubo syndrome. This joint scientific statement reviews the vascular pathophysiology, role of sex hormones, genetics, and chronic cardiovascular abnormalities in Takotsubo syndrome.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: